[{"id":"0367ee49-0836-46f6-bf51-056530d84456","acronym":"COLEMAN","url":"https://clinicaltrials.gov/study/NCT05029791","created_at":"2021-09-01T14:52:58.063Z","updated_at":"2024-07-02T16:35:26.104Z","phase":"","brief_title":"Variations of Immune Infiltrate and Cell Plasticity Markers in Treated Metastatic Melanoma Patients","source_id_and_acronym":"NCT05029791 - COLEMAN","lead_sponsor":"Hospices Civils de Lyon","biomarkers":" CD8 • ZEB1","pipe":" | ","alterations":" CD8 expression • ZEB1 expression","tags":["CD8 • ZEB1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD8 expression • ZEB1 expression"],"overall_status":"Recruiting","enrollment":" Enrollment 100","initiation":"Initiation: 08/18/2022","start_date":" 08/18/2022","primary_txt":" Primary completion: 11/18/2031","primary_completion_date":" 11/18/2031","study_txt":" Completion: 11/18/2031","study_completion_date":" 11/18/2031","last_update_posted":"2023-12-15"},{"id":"e6fa6f5f-f47f-4e45-ac2a-8106517e9c98","acronym":"","url":"https://clinicaltrials.gov/study/NCT04021394","created_at":"2021-01-18T19:44:45.886Z","updated_at":"2024-07-02T16:35:51.538Z","phase":"","brief_title":"Influence of EMT on CTCs and Disease Progression in Prostate Cancer","source_id_and_acronym":"NCT04021394","lead_sponsor":"Lawson Health Research Institute","biomarkers":" CDH1 • EPCAM • CDH2 • ZEB1","pipe":" | ","alterations":" AR expression • CDH1 expression • EPCAM expression • ZEB1 expression","tags":["CDH1 • EPCAM • CDH2 • ZEB1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AR expression • CDH1 expression • EPCAM expression • ZEB1 expression"],"overall_status":"Completed","enrollment":" Enrollment 31","initiation":"Initiation: 06/05/2019","start_date":" 06/05/2019","primary_txt":" Primary completion: 04/27/2021","primary_completion_date":" 04/27/2021","study_txt":" Completion: 12/01/2022","study_completion_date":" 12/01/2022","last_update_posted":"2023-04-04"}]